Live·Open questions in longevity research
All news
Longevity researchTherapeutics

Old mice retain the same amount of HNF4α, a protein that regulates liver cells, but it binds DNA less effectively; delivering its gene to the liver reduced fat and activated some fat metabolism genes, according to a preprint that has yet to undergo peer review

12 November 2026· 261112009

Old mice retain the same amount of HNF4α, a protein that regulates liver cells, but it binds DNA less effectively; delivering its gene to the liver reduced fat and activated some fat metabolism genes, according to a preprint that has yet to undergo peer review

In a preprint dated November 9, Peter Adams's group at Sanford Burnham Prebys compared the livers of male mice aged 4–5 and 22–23 months. Inactivating the gene encoding this protein in young mice reproduced about 63% of the age-related changes in gene expression.

HNF4α is a major regulator of hepatocytes, the cells of the liver. It is a transcription factor: a protein that binds DNA near genes and switches them on or off. In the liver, it activates genes involved in metabolism and suppresses genes involved in cell division, migration, and inflammation that a mature cell does not need. In old mice, metabolic genes are less active, and the liver contains more fat.

In 2017, Adams's group showed that calorie restriction and rapamycin, both of which extend lifespan in mice, suppress some age-related changes in methylation, the chemical marks on liver DNA. Drawing on this and related work, the authors conclude that age-related liver dysfunction partly reflects hepatocytes' inability to maintain the activity of essential genes.

A computational analysis of genes whose expression declined with age identified HNF4α as the most likely regulator to have lost activity, even though its RNA and protein levels remained unchanged. CUT&RUN, a method that maps where a protein binds DNA, detected fewer occupied sites in old mice.

To test whether HNF4α loss reproduces liver aging, the researchers used the viral vector AAV8 to deliver CRISPR gene-editing machinery into mouse hepatocytes to inactivate Hnf4a. After three weeks, young mice showed changes resembling those seen with aging: metabolic gene expression declined, and the interferon response increased (this cellular response to an antiviral signal sustains inflammation). Lipid droplets and immune cells also increased. In old mice, inactivating the same gene further increased fat accumulation and inflammation, indicating that their livers still depend on the remaining HNF4α.

Direct targets of HNF4α are genes near its binding sites whose expression changes when it is removed. Two-thirds of its direct targets in young livers showed no appreciable change in old mice. Many targets whose expression declined were involved in fatty acid breakdown and mitochondrial function, while genes involved in fat storage became more active. The authors propose that these changes may explain how fat accumulates.

To test whether these changes could be reversed, the researchers delivered an additional copy of the HNF4α gene into hepatocytes in old mice. Within three weeks, the liver contained fewer lipid droplets, fat and cholesterol levels fell, and some genes involved in fat metabolism and mitochondrial function became active again. The interferon response remained elevated. The authors explain this difference as follows: HNF4α directly activates 751 of the 1194 genes whose expression declined both with aging and after Hnf4a inactivation, but suppresses only 209 of the 1467 genes whose expression increased under both conditions. They suggest that inflammatory gene expression increases through secondary signals triggered by the loss of HNF4α activity.

The authors propose a feedback loop: at HNF4α binding sites, chromatin (DNA packaged with proteins) becomes more tightly packed, making it harder for the protein to bind. In turn, less active HNF4α is less able to keep chromatin open. These sites are only partly closed, consistent with the liver's response to the additional protein.

In 2015, a viral vector carrying the HNF4α gene reversed fatal liver failure in rats with cirrhosis. The gene has now been tested in naturally aged mice. The authors suggest:

“Targeting transcription factors that determine cell identity may offer a strategy for reversing specific features of tissue aging even when levels of the factor itself remain unchanged.”
Originally published on Telegram by Ukhvat NewsView on Telegram
Sources
#hnf4a#liver-aging#gene-therapy#fat-metabolism#aav8#hepatocytes